Newron Pharmaceuticals acquires NeuroNova - MarketLine Financial Deals

Newron Pharmaceuticals acquires NeuroNova

Newron Pharmaceuticals acquires NeuroNova - MarketLine Financial Deals
Newron Pharmaceuticals acquires NeuroNova
Published Dec 17, 2012
3 pages — Published Dec 17, 2012
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

Newron Pharmaceuticals S.p.A, an Italy-based biopharmaceutical company, has acquired 100% stake of NeuroNova.

  
Source:
Document ID
MA113019_120615
Country
Country
Ticker
NWRN=IT
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "Newron Pharmaceuticals acquires NeuroNova" Dec 17, 2012. Alacra Store. Dec 11, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Newron-Pharmaceuticals-acquires-NeuroNova-2052-82887>
  
APA:
MarketLine Financial Deals. (2012). Newron Pharmaceuticals acquires NeuroNova Dec 17, 2012. New York, NY: Alacra Store. Retrieved Dec 11, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Newron-Pharmaceuticals-acquires-NeuroNova-2052-82887>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.